University of Pisa
Francesco Lippi is Graduated in Medicine and Surgery at the University of Pisa, Albo Pisa 1879/79. Specialization in Endocrinology at the University of Pisa July 1982. Specialization in Nuclear Medicine at the University of Florence July 1987. He has taught at the Institute of Clinical Methodology and the Institute of Endocrinology of the University of Pisa. From 1990 as a Professor of Endocrinology at the University Hospital of Pisa. He conducted the study (pahe se III) on effects of recombinant human TSH (rhTSH) adjuvant therapy in compassionate use program for patients with differentiated thyroid carcinoma. Then used a low activiy of radiodine therapy for treatment of thyroid remnants after surgery using rhTSH therapy without widrawall l-tiroxine. After Chernobyl accident partecipate to European Commision Study for diagnosis and tratment of children exposed to the radiations or radioactive follow-out (1990-1995). He held master's and refresher courses in Endocrinology and Nuclear Medicine at Stanford University (USA) for the treatment of thyroid carcinoma with rhTSH. He held an update master's degree at the Mayo Clinic in Rochester (USA). Associate of scientific associations in the field of Endocrinology as Endocrine Society, American Thyroid Association, European Thyroid Association and Medical Endocrinolist Association (AME).
Endocrinology, Nuclear Medicine, thyroid carcinoma